The use of psychedelic compounds has been met with controversy, and the industry faces unique barriers to development and access. As the burden of clinical efficacy evidence grows, the industry has seen an explosion in interest by Pharma, biotech and the investment community.
The inaugural Psychedelic Drug Development Digital Summit will gather the best and brightest minds harnessing natural and synthetic psychoactive substances to treat depression, addiction, anxiety and many more life debilitating psychiatric conditions.
Event Date: October 21 – 22, 2020
Event Link: www.psychedelic-drug-development.com